Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis

被引:60
作者
Ben-Arieh, SV
Zimerman, B
Smorodinsky, NI
Yaacubovicz, M
Schechter, C
Bacik, I
Gibbs, J
Bennink, JR
Yewdell, JW
Coligan, JE
Firat, H
Lemonnier, F
Ehrlich, R [1 ]
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel
[2] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[3] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA
[4] Inst Pasteur, Unite Immunite Cellulaire Antivirale, Paris, France
关键词
D O I
10.1128/JVI.75.21.10557-10562.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
HFE is a nonclassical class I major histocompatibility complex (MHC) molecule that is mutated in the autosomal recessive iron overload disease hereditary hemochromatosis. There is evidence linking HFE with reduced iron uptake by the transferrin receptor (TfR). Using a panel of HFE and TfR monoclonal antibodies to examine human HFE (hHFE) -expressing cell lines, we demonstrate the expression of stable and fully glycosylated TfR-free and TfR-associated hHFE/beta 2m complexes. We show that both the stability and assembly of hHFE complexes can be modified by the human cytomegalovirus (HCMV) viral protein US2, known to interfere with the expression of classical class I MHC molecules. HCMV US2, but not US11, targets FIFE molecules for degradation by the proteasome. Whether this interference with the regulation of iron metabolism by a viral protein is a means of potentiating viral replication remains to be determined. The reduced expression of classical class I MHC and FIFE complexes provides the virus with an efficient tool for altering cellular metabolism and escaping certain immune responses.
引用
收藏
页码:10557 / 10562
页数:6
相关论文
共 49 条
[1]
Control of iron absorption [J].
Anderson, GJ .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (11) :1030-1032
[2]
HUMAN CYTOMEGALO-VIRUS ENCODES A GLYCOPROTEIN HOMOLOGOUS TO MHC CLASS-I ANTIGENS [J].
BECK, S ;
BARRELL, BG .
NATURE, 1988, 331 (6153) :269-272
[3]
Bennett EM, 1999, J IMMUNOL, V162, P5049
[4]
Cagnoni C, 2000, Ann Ital Med Int, V15, P132
[5]
VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES [J].
CHAKRABARTI, S ;
BRECHLING, K ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3403-3409
[6]
DESOUSA M, 1991, CURR STUD HEMATOL BL, V58, P171
[7]
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial [J].
Di Bisceglie, AM ;
Bonkovsky, HL ;
Chopra, S ;
Flamm, S ;
Reddy, RK ;
Grace, N ;
Killenberg, P ;
Hunt, C ;
Tamburro, C ;
Tavill, AS ;
Ferguson, R ;
Krawitt, E ;
Banner, B ;
Bacon, BR .
HEPATOLOGY, 2000, 32 (01) :135-138
[8]
HFE - A novel nonclassical class I molecule that is involved in iron metabolism [J].
Ehrlich, R ;
Lemonnier, FA .
IMMUNITY, 2000, 13 (05) :585-588
[9]
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding [J].
Feder, JN ;
Penny, DM ;
Irrinki, A ;
Lee, VK ;
Lebrón, JA ;
Watson, N ;
Tsuchihashi, Z ;
Sigal, E ;
Bjorkman, PJ ;
Schatzman, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1472-1477
[10]
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408